Securing Seed Funding: Support for Biotech Entrepreneurs and Researchers
Thursday, July 6, 2017, 2:30 PM - 3:30 PM EDT
On July 6, 2:30 – 3:30 p.m. ET, join the National Center for Advancing Translational Sciences (NCATS) and New York Academy of Sciences’ (NYAS) Science Alliance for a webinar about funding and resources for researchers and entrepreneurs focused on advancing translational research and technologies that will improve disease prevention, detection and treatment.
There are many benefits to securing SBIR or STTR funding: The capital is nondilutive, predictable and stable; it is not a loan. In addition, small businesses retain intellectual property rights, and NIH’s rigorous peer-review provides recognition, validation and visibility to early-stage companies.
There are a number of current SBIR and STTR funding opportunities for small businesses and technology transfer organizations available, including through the recently opened 2017 Omnibus Solicitation.
The webinar will feature:
An overview of SBIR and STTR programs and funding opportunities
Examples and case studies of founders of bio- and healthcare technology early-stage businesses
Tips and tools for applying for funding
Additional resources available for researchers, entrepreneurs, students and others seeking seed funding for a small business
This event is open to the scientific community and registration is required.
Lili Portilla, M.P.A.
Director of Strategic Alliances
National Center for Advancing Translational Sciences
National Institutes of Health
Lili Portilla has worked in the area of strategic alliances and technology transfer at NIH since 1989, joining NCATS in December 2011. She oversees the Center’s partnership, strategic alliance and technology transfer functions as well as NCATS’ Small Business Innovation Research and Small Business Technology Transfer programs. Before coming to NCATS, Portilla served as senior advisor to the director of the National Center for Research Resources and as the director of the Office of Technology Transfer and Development at the National Heart, Lung and Blood Institute. Portilla is an ex officio board member of the University of Kansas Institute for Advancing Medical Innovation.
Portilla received a master’s degree in public administration in 1992 from American University and a bachelor’s degree in business administration in 1986 from Stephen F. Austin State University, where she majored in finance and Spanish literature.